Breves Christine S 4

What Happened

• Christine S. Breves, a director of MPLX GP LLC (the general partner of MPLX LP), received an award of 218.103 shares/units on February 17, 2026. The reported acquisition price is $0.00, so the grant was issued as compensation rather than a purchase (total reported cash value: $0).

Key Details

• Transaction date: 2026-02-17. Form 4 filed: 2026-02-19 (appears timely; Form 4 is generally due within two business days).
• Transaction code: A (grant/award/other acquisition). Amount: 218.103 shares; price per share: $0.00; total cash reported: $0.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote/relationship: Reporting person is a director of MPLX GP LLC, the general partner; the issuer is managed by the directors and executive officers of MPLX GP LLC.
• No 10b5-1 plan, tax-withholding sale, option exercise, or immediate sale of awarded shares is indicated in the filing excerpt.

Context

• This was a compensatory award (typical for directors) rather than a market purchase — awards can vest over time or carry restrictions, so they don’t necessarily signal immediate bullish or bearish intent.
• No immediate sale or option exercise was reported, and the filing does not disclose any vesting schedule or post-grant disposition in the excerpt provided.